发明申请
US20070099901A1 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
有权
羟胺和肟取代的咪唑并喹啉，咪唑并吡啶和咪唑并吡啶类
- 专利标题： Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
- 专利标题（中）： 羟胺和肟取代的咪唑并喹啉，咪唑并吡啶和咪唑并吡啶类
-
申请号： US10595895申请日： 2004-11-24
-
公开(公告)号： US20070099901A1公开(公告)日： 2007-05-03
- 发明人: Larry Krepski , Joseph Dellaria , Daniel Duffy , David Amos , Bernhard Zimmermann , David Squire , Gregory Marszalek , Philip Heppner , Tushar Kshirsagar
- 申请人： Larry Krepski , Joseph Dellaria , Daniel Duffy , David Amos , Bernhard Zimmermann , David Squire , Gregory Marszalek , Philip Heppner , Tushar Kshirsagar
- 申请人地址： US MN Saint Paul, 55133-3427
- 专利权人： 3M INNOVATIVE PROPERTIES COMPANY
- 当前专利权人： 3M INNOVATIVE PROPERTIES COMPANY
- 当前专利权人地址： US MN Saint Paul, 55133-3427
- 国际申请： PCT/US04/39673 WO 20041124
- 主分类号： A61K31/551
- IPC分类号： A61K31/551 ; A61K31/541 ; A61K31/5377 ; A61K31/496 ; A61K31/4745 ; C07D471/02
摘要：
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
公开/授权文献
信息查询
